Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 1
2016 2
2017 2
2018 2
2019 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis.
Veroniki AA, Ashoor HM, Rios P, Seitidis G, Stewart L, Clarke M, Tudur-Smith C, Mavridis D, Hemmelgarn BR, Holroyd-Leduc J, Straus SE, Tricco AC. Veroniki AA, et al. Among authors: ashoor hm. BMJ Open. 2022 Apr 26;12(4):e053012. doi: 10.1136/bmjopen-2021-053012. BMJ Open. 2022. PMID: 35473731 Free PMC article.
Absorptive capacity in the adoption of innovations in health: a scoping review.
Godfrey CM, Kircher C, Ashoor HM, Ross-White A, Glandon L, Wilson R, McSharry J, Tricco AC, Zitzelsberger L, Kaan D, Sears K. Godfrey CM, et al. Among authors: ashoor hm. JBI Evid Synth. 2023 Jan 1;21(1):6-32. doi: 10.11124/JBIES-21-00436. JBI Evid Synth. 2023. PMID: 35942617 Review.
The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review.
Saunders H, Pham B, Loong D, Mishra S, Ashoor HM, Antony J, Darvesh N, Bains SK, Jamieson M, Plett D, Trivedi S, Yu CH, Straus SE, Tricco AC, Isaranuwatchai W. Saunders H, et al. Among authors: ashoor hm. Value Health. 2022 Jul;25(7):1235-1252. doi: 10.1016/j.jval.2021.12.016. Epub 2022 Mar 24. Value Health. 2022. PMID: 35341688 Free article. Review.
Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis.
Tricco AC, Ashoor HM, Antony J, Bouck Z, Rodrigues M, Pham B, Khan PA, Nincic V, Darvesh N, Yazdi F, Ghassemi M, Ivory JD, Veroniki AA, Yu CH, Moja L, Straus SE. Tricco AC, et al. Among authors: ashoor hm. J Gen Intern Med. 2021 Aug;36(8):2414-2426. doi: 10.1007/s11606-021-06642-7. Epub 2021 Mar 19. J Gen Intern Med. 2021. PMID: 33742305 Free PMC article. Review.
Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis.
Tricco AC, Ashoor HM, Antony J, Beyene J, Veroniki AA, Isaranuwatchai W, Harrington A, Wilson C, Tsouros S, Soobiah C, Yu CH, Hutton B, Hoch JS, Hemmelgarn BR, Moher D, Majumdar SR, Straus SE. Tricco AC, et al. Among authors: ashoor hm. BMJ. 2014 Oct 1;349:g5459. doi: 10.1136/bmj.g5459. BMJ. 2014. PMID: 25274009 Free PMC article. Review.
17 results